73%
of retail accounts lose money when trading CFDs with this provider.
Investments involve risks and are not suitable for all investors. CFDs are complex instruments and come with a high risk of losing money rapidly due to leverage.
73%
of retail investor accounts lose money when trading CFDs with this provider.
You should consider whether you understand how CFDs work, and whether you can afford to take the high risk of losing your money.
73%
of retail accounts lose money when trading CFDs with this provider.
Investments involve risks and are not suitable for all investors. CFDs are complex instruments and come with a high risk of losing money rapidly due to leverage.
73%
of retail investor accounts lose money when trading CFDs with this provider.
You should consider whether you understand how CFDs work, and whether you can afford to take the high risk of losing your money.
English (International)
Reckitt Benckiser Group PLC
Open
SectorFinance
6,092 0.3
Overview
Share price change
24h
Min
5898
Max
6092
Income | 479M |
|---|---|
Sales | 3.5B |
P/E Sector Avg | 31.891 27.305 |
EPS | 1.41 |
Dividend yield | 3.5 |
Profit margin | 13.723 |
Employees | 37,900 |
EBITDA | 867M |
Recommendations | Buy |
|---|---|
12 Months Forecast | +3.99% upside |
Dividend yield Sector Avg | 3.50% 4.21% |
|---|---|
Next Earnings | 5 Mar 2026 |
Market Cap | 2.4B 39B |
|---|---|
Previous open | 6091.7 |
Previous close | 6092 |
News Sentiment
By Acuity
29%
71%
74 / 493 Finance
Reckitt Benckiser Group PLC Chart
Past performance is not a reliable indicator of future results.
Related News
Peer Comparison
Price change
Reckitt Benckiser Group PLC Forecast
Price Target
By TipRanks
3.99% upside
12 Months Forecast
Average 6,349.73 GBX 3.99%
High 7,800 GBX
Low 5,647 GBX
Based on 12 Wall Street analysts offering 12 month price targets forReckitt Benckiser Group PLC - Dist in the last 3 months.
Sentiment
By Acuity
74 / 493 Finance
News Sentiment
Bullish Evidence
Volatility
Below average
News Volume (RCV)
Above average
Financials
Selling and administration expenses
Operating expenses
Pre-tax profit
Sales
Cost of sales
Gross profit on sales
Interest expense on debt
EBITDA
Operating profit
$
About Reckitt Benckiser Group PLC
Reckitt Benckiser Group plc manufactures and sells health, hygiene, and nutrition products worldwide. It offers acne treatment creams, facial washes, and cleansing pads; germ protection products; condoms; heartburn and indigestion solutions; joints health products; chest congestion, cough, and sinus remedies; brain health products; migraine-headaches and rheumatic pain products; sore throat medications; and hair removal products under the Airborne, Clearasil, Dettol, Durex, Gaviscon, Move Free, Neuriva, Nurofen, Mucinex, Strepsils, and Veet brands. The company also offers home fragrances and devices; water softeners; home cleaning products; dish washes; toilet cleaners; disinfecting sprays wipes, laundry sanitisers, and others; sprays, baits, and plug-ins for pest control; stain removals; and fabric washing under the Air Wick, Calgon, Cillit Bang, Finish, Harpic, Lysol, Mortein, Vanish, and Woolite brands. In addition, it provides nutritious complementary foods and milk formulas for infant and young children under the Enfamil and Nutramigen brands. The company was founded in 1819 and is headquartered in Slough, the United Kingdom.
Other stocks from the sector
Live chat